Stock of the Day

March 23, 2021

Cooper Companies (COO)

$71.71
-$1.39 (-1.9%)
Market Cap: $14.26B

About Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Today's Trend

The Cooper Companies, Inc. (NASDAQ: COO) is trading higher as investors react to a wave of positive analyst revisions and growing speculation around a potential sale of its CooperSurgical business.

  • Stifel reiterated a Buy rating on Cooper Companies while sale talks involving CooperSurgical reportedly continue, which is fueling investor optimism that the company could unlock value through a divestiture. Stifel Backs Cooper Companies (COO) as CooperSurgical Sale Talks Progress
  • Zacks Research raised multiple earnings estimates for Cooper Companies across 2026-2028, including higher forecasts for FY2026, FY2027, and FY2028. Higher earnings expectations can support the stock by suggesting stronger long-term profitability.
  • Recent short-interest data showed 0 shares of short interest, offering little actionable signal for the stock.

Overall, Cooper Companies (COO) appears to be benefiting from improving analyst sentiment and hopes that a strategic sale could highlight hidden value, which helps explain the stock’s upward move.

← Previous Stock of the DayNext Stock of the Day →

Recent News